Thank you for joining us today. Industry Innovations Webinars are archived on the ATS YouTube channel under the Industry Innovation playlist. https://www.youtube.com/playlist?list=PLFyO68a-Ji3n0xo20dmiQGvtDk9e2dKeH
Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.
Brigham and Women’s Hospital (BWH)
Director, Pulmonary Vascular Disease
Program
Dr. Aaron B. Waxman is the director of the Pulmonary
Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate
professor of medicine at Harvard Medical School.
After receiving his medical degree from Yale University
School of Medicine, Dr. Waxman completed a residency in internal medicine at
Yale New Haven Hospital. He then completed two fellowships: the first at Howard
Hughes Medical Institute, and the second in pulmonary and critical care at Yale
New Haven Hospital. He is board certified in critical care medicine, internal
medicine and pulmonary disease.
Dr. Waxman’s clinical interests include pulmonary arterial
hypertension (PAH), right heart failure, thromboembolic disease and pulmonary
vascular disease. His research focuses on the inflammatory mechanisms of
pulmonary vascular remodeling that lead to right heart failure. His research
into the regulation of cell death proteins by IL-6 cytokines in mice led to the
discovery of a relationship between dyspnea and mitochondrial dysfunction, and
resulted in additional clinical studies examining the abnormalities of
inflammatory mediators and oxygen extraction in patients with PAH. He has
authored over 110 peer-reviewed publications and has received funding from the
National Institutes of Health and the National Heart, Lung, and Blood
Institute.